2026 · Featured faculty video
UC Berkeley 101 in 101 Series
UC Berkeley News
Reprogramming gut bacteria to fight disease
Conversations, talks, and coverage of the Ronda Lab, with background information for journalists.
Hear Carlotta discuss microbiome research with scientists, journalists, and public audiences.
2026 · Featured faculty video
UC Berkeley News
Reprogramming gut bacteria to fight disease
2025 · Video interview
Curious by Nature · Newswise
Synthetic biology and precision microbiome editing
2024 · Podcast
Biomes Podcast with Ruairi Robertson
CRISPR microbiome engineering
2020 · Podcast
The Gastronauts Podcast
Modifying microbial communities in the gut
2025 · Panel
Washington, D.C.
Food allergy research and innovation
2025 · Panel
UC Berkeley College of Letters & Science, Basic Science Lights the Way
A decade of CRISPR, and the next one
2025 · Invited talk
UCSF
Programming the microbiome in situ
2023 · Lecture
SynBYSS seminar with Ting Lu and Carlotta Ronda
Synthetic microbial communities and microbiome engineering
founded
October 2023
institution
Innovative Genomics Institute, UC Berkeley
pi
Carlotta Ronda, PhD
publications
15+ peer-reviewed papers in Nature Methods, Science, Nature Biotechnology, Nature Biomedical Engineering, and more
research methods
In situ microbial delivery, CRISPR-associated transposase engineering, precision genome writing, high-throughput culturomics, and host-microbiome models
focus areas
In situ microbiome engineering, host-microbiome interactions, living therapeutics, AI-guided protein discovery
The Ronda Lab at UC Berkeley's Innovative Genomics Institute studies host–microbe interactions and develops tools to edit microbial DNA within living communities. The group combines microbial genome engineering, AI-guided discovery, culturomics, and human organoid systems to investigate host-microbe communication.
The Ronda Lab at the Innovative Genomics Institute, UC Berkeley, develops methods for editing the mammalian gut microbiome in vivo and mapping host-microbe signaling. Carlotta Ronda's published work includes MAGIC and CRISPR-associated transposase systems such as INTEGRATE. The Berkeley lab combines microbial genome engineering with AI-guided discovery, high-throughput interactome mapping, and human-derived gut organoids to investigate causal mechanisms along the gut-immune-brain axis. PI Carlotta Ronda is a WIES Fellow and former Simons Society Junior Fellow with contributions spanning CRISPR engineering in prokaryotic and eukaryotic systems.
Dr. Carlotta Ronda is a Principal Investigator at the Innovative Genomics Institute at UC Berkeley. Before founding her Berkeley lab, her work at Columbia included MAGIC and CRISPR-associated transposase approaches for delivering and writing DNA in microbial communities. Her research has also contributed to methods for precise editing of commensal bacteria and gut pathogens. She is a WIES Fellow and former Simons Society Junior Fellow.
Carlotta Ronda explains CRISPR microbiome editing in the 101 in 101 video series.
Read coverageBACTRINS disabled Shiga toxin genes in gut bacteria and improved survival in a mouse infection model.
Read coverageIn mice, targeted DNA insertion disabled a Shiga toxin gene in gut bacteria while adding a gene for a protective protein.
Read coverageThe Audacious Project supports an IGI initiative to develop CRISPR microbiome editing for human health and climate applications.
Read coverageFor interview requests or background questions, contact Dr. Carlotta Ronda at cronda (at) berkeley.edu.
Media may also contact UC Berkeley or IGI communications offices for institutional coordination.